NDC 0944-2884
Glassia 1 g per 50 mL injection, solution
On the label: Takeda Pharmaceuticals America, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxalta Belgium Manufacturing SA | Lessines, Belgium | Makes it, makes the active ingredient, tests it, packages it and labels it | Problems found, fixed voluntarilyJun 18, 2013 · 1 inspection |
| Baxalta Us Inc. | Los Angeles, CA, United States | Makes the active ingredient | Not inspected on record |
| SGS Lab Simon | Wavre (Bierges), Belgium | Tests it | Problems found, fixed voluntarilyMar 10, 2025 · 5 inspections |
| Takeda Manufacturing Austria AG | Wien, Austria | Tests it | Not inspected on record |
| Takeda Manufacturing Austria AG | Orth an der Donau, Austria | Tests it | No problems foundApr 24, 2024 · 1 inspection |
Product details
- Generic drug
- .alpha.1-Proteinase Inhibitor Human: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 1 g per 50 mL
- Approval
- BLA BLA125325
- On the market since
- Jul 1, 2010
- Package NDCs
0944-2884-010944-2884-020944-2884-030944-2884-040944-2884-050944-2884-06- Official label
- DailyMed (National Library of Medicine), updated Dec 2, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?